Investigation of HLA susceptibility alleles and genotypes with hematological disease among Chinese Han population
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0281698 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ye-Mo Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China. Hauptthemen laut MEDLINE: Histocompatibility Antigens Class I, Hematologic Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Projects subsidized by special funds for science technology innovation and industrial development of Shenzhen Dapeng New District.
Abstract (Originalsprache)
Several genes involved in the pathogenesis have been identified, with the human leukocyte antigen (HLA) system playing an essential role. However, the relationship between HLA and a cluster of hematological diseases has received little attention in China. Blood samples (n = 123913) from 43568 patients and 80345 individuals without known pathology were genotyped for HLA class I and II using sequencing-based typing. We discovered that HLA-A*11:01, B*40:01, C*01:02, DQB1*03:01, and DRB1*09:01 were prevalent in China. Furthermore, three high-frequency alleles (DQB1*03:01, DQB1*06:02, and DRB1*15:01) were found to be hazardous in malignant hematologic diseases when compared to controls. In addition, for benign hematologic disorders, 7 high-frequency risk alleles (A*01:01, B*46:01, C*01:02, DQB1*03:03, DQB1*05:02, DRB1*09:01, and DRB1*14:54) and 8 high-frequency susceptible genotypes (A*11:01-A*11:01, B*46:01-B*58:01, B*46:01-B*46:01, C*01:02-C*03:04, DQB1*03:01-DQB1*05:02, DQB1*03:03-DQB1*06:01, DRB1*09:01-DRB1*15:01, and DRB1*14:54-DRB1*15:01) were observed. To summarize, our findings indicate the association between HLA alleles/genotypes and a variety of hematological disorders, which is critical for disease surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China.
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China.
ORCID-Profile: Zhong-Zheng Zheng
Förderung
- Projects subsidized by special funds for science technology innovation and industrial development of Shenzhen Dapeng New District
Zitieren
APA
Li, Y. M., Li, Y. X., Li, D. Y., Zhou, Y., An, L., Yuan, Z. Y., Du, K. M., & Zheng, Z. Z. (2024). Investigation of HLA susceptibility alleles and genotypes with hematological disease among Chinese Han population. PLOS ONE. https://doi.org/10.1371/journal.pone.0281698
Vancouver
Li YM, Li YX, Li DY, Zhou Y, An L, Yuan ZY, et al. Investigation of HLA susceptibility alleles and genotypes with hematological disease among Chinese Han population. PLOS ONE. 2024. doi:10.1371/journal.pone.0281698
BibTeX
@article{Li2024,
author = {Li, Ye-Mo and Li, Yu-Xia and Li, Dai-Yang and Zhou, Ying and An, Lin and Yuan, Zhi-Yang and Du, Ke-Ming and Zheng, Zhong-Zheng},
title = {Investigation of HLA susceptibility alleles and genotypes with hematological disease among Chinese Han population},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0281698}
}
EUVIMED